Consumer Business An Asset To Pfizer, A Divestment Chip To Analysts
This article was originally published in The Pink Sheet
Executive Summary
CEO Ian Read says selling the consumer business has to do more than boost Pfizer's treasury. "If there is a better mix, we are always open to it, but it has to be for strategic reasons rather than cash," he says.